{"id":57066,"date":"2014-01-21T10:52:18","date_gmt":"2014-01-21T15:52:18","guid":{"rendered":"http:\/\/www.bu.edu\/experts\/?post_type=profile&#038;p=57066"},"modified":"2019-10-31T15:07:12","modified_gmt":"2019-10-31T19:07:12","slug":"robert-stern","status":"publish","type":"profile","link":"https:\/\/www.bu.edu\/prsocial\/profile\/robert-stern\/","title":{"rendered":"Robert Stern"},"content":{"rendered":"<p>Dr. Robert Stern is Professor of Neurology and Neurosurgery at Boston University School of Medicine (BUSM), where he was also\u00a0Co- Director of the Center for the Study of Traumatic Encephalopathy\u00a0as well as Director of the Clinical Core of the\u00a0BU Alzheimer\u2019s Disease Center, one of only 30 centers funded by the National Institutes of Health (NIH).\u00a0 A major focus of his research involves the long-term effects of repetitive brain trauma in athletes and the military, including chronic traumatic encephalopathy (CTE).\u00a0 He recently received a grant from NIH to fund his work on developing methods of detecting and diagnosing CTE during life; this was the first grant for CTE ever funded by NIH (co-funded by the National Institute of Neurological Disorders and Stroke, the National Institute on Aging, and the National Institute of Child Health and Human Development). \u00a0Dr. Stern oversees all aspects of clinical research at the CSTE, including the\u00a0Brain Donation Registry,\u00a0the LEGEND study,and the DETECT study.<\/p>\n<p>Dr. Stern\u2019s other areas of funded research include thyroid-brain relationships (funded by the National Institute of Mental Health), the cognitive effects of chemotherapy in the elderly (funded by the National Cancer Institute, with colleagues at Georgetown and Memorial Sloan Kettering Cancer Institute),driving and dementia\u00a0(funded by the Alzheimer\u2019s Association), and the assessment and treatment of Alzheimer\u2019s disease.\u00a0 He is the principal investigator at BUSM for several clinical trials of\u00a0\u00a0new drugs for the treatment of Alzheimer\u2019s disease, as well as the NIH-funded Alzheimer\u2019s Disease Anti-inflammatory Prevention Trial (ADAPT).<\/p>\n","protected":false},"author":11144,"template":"","_links":{"self":[{"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/profile\/57066"}],"collection":[{"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/profile"}],"about":[{"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/types\/profile"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/users\/11144"}],"version-history":[{"count":1,"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/profile\/57066\/revisions"}],"predecessor-version":[{"id":70893,"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/profile\/57066\/revisions\/70893"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/media?parent=57066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}